Geometrically Tunable Scaffold‐Free Muscle Bioconstructs for Treating Volumetric Muscle Loss
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202501887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Bugra Ayan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Stanford University, Stanford, CA, 94305, USA. Hauptthemen laut MEDLINE: Muscle, Skeletal, Tissue Engineering, Tissue Scaffolds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Veterans Affairs, NHLBI NIH HHS, American Heart Association.
Abstract (Originalsprache)
Traumatic muscle injuries associated with volumetric muscle loss (VML) are characterized by muscle loss beyond intrinsic regeneration capacity, leading to permanent functional impairment. Experimental therapies to augment muscle regeneration, such as cell injection, are limited by low cell transplantation capacity, whereas conventional engineered muscle tissue transplants lack geometric customization to conform to the shape of the muscle defect. Here, a facile approach to engineer scaffold‐free high‐density muscle tissues in customizable geometric shapes and sizes with high cell viability and integration potential is developed. Using a facile mold‐based approach to engineer scaffold‐free modular units, transcriptional profiling is performed to uncover the role of pre‐formed cell–cell interactions within scaffold‐free muscle bioconstructs on myogenesis, an the efficacy of muscle bioconstructs in a mouse model of VML is then evaluated. RNA sequencing revealed that pre‐formed cell–cell interactions supported myogenic pathways related to muscle contraction and myofibril assembly, unlike dissociated monodisperse cells. This work further demonstrates the therapeutic efficacy of 3D rectangular solid‐shaped scaffold‐free transplants in improving muscle function and vascular regeneration. Finally, toward clinical translation, the feasibility of this technology to integrate with medical imaging and artificial intelligence‐driven customized bioconstruct design and assembly for intraoperative use is illustrated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Stanford University, Stanford, CA, 94305, USA.
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, 94305, USA.
- Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
- Department of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
ORCID-Profile: Ngan F Huang
Förderung
- U.S. Department of Veterans Affairs
- NHLBI NIH HHS
- American Heart Association
- NIH HHS
- RRD VA
- NCI NIH HHS
- BLRD VA
- National Science Foundation
Zitieren
APA
Ayan, B., Chen, G., Jain, I., Chen, S., Chiang, G., Hu, C., Reyes, R., Oropeza, B. P., & Huang, N. F. (2026). Geometrically Tunable Scaffold‐Free Muscle Bioconstructs for Treating Volumetric Muscle Loss. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501887
Vancouver
Ayan B, Chen G, Jain I, Chen S, Chiang G, Hu C, et al. Geometrically Tunable Scaffold‐Free Muscle Bioconstructs for Treating Volumetric Muscle Loss. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202501887
BibTeX
@article{Ayan2026,
author = {Ayan, Bugra and Chen, Gaoxian and Jain, Ishita and Chen, Sha and Chiang, Gladys and Hu, Caroline and Reyes, Renato and Oropeza, Beu P and Huang, Ngan F},
title = {Geometrically Tunable Scaffold‐Free Muscle Bioconstructs for Treating Volumetric Muscle Loss},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202501887}
}
EUVIMED